{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-001670","form_type":"8-K","ticker":null,"cik":"0001419051","company_name":"THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.581866+00:00","generated_at":"2026-05-28T04:45:51.428724+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Therapeutic Solutions International increases authorized common stock from 6.5B to 9.0B shares","bullets":["Authorized common stock increased from 6.5 billion to 9.0 billion shares (par $0.001) via Certificate of Amendment filed Jan 7, 2025.","Amendment approved by nonunanimous majority written consent of stockholders; Series A Preferred holder has effective voting control.","Series A Preferred (held by Timothy G. Dixon and Thomas E. Ichim) votes 1M + fully diluted common votes, ensuring control.","Preferred stock authorization unchanged at 5 million shares; no change to fiscal year."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-001670","json":"https://secwatch.observer/filing/0001493152-25-001670.json","markdown":"https://secwatch.observer/filing/0001493152-25-001670.md","text":"https://secwatch.observer/filing/0001493152-25-001670.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419051/000149315225001670/0001493152-25-001670-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419051/000149315225001670/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:45:51.428724+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07b205864eba4070db6cda01792b2348d173cc39","claim":"THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: Increased authorized shares from 6.5 billion to 9 billion common shares, par value unchanged at $0.001, and 5 million preferred shares still authorized (effective 2025-01-07).","evidence_excerpt":"On January 07, 2025, we caused to be filed with the Nevada Secretary of State a Certificate of Amendment to Articles of Incorporation to effect an amendment (the “Amendment”) increasing the aggregate number of shares which the corporation shall have authority to issue from 6,500,000,000 to 9,000,000,000 shares of stock having a $.001 par value per share, and 5,000,000 shares of Preferred Stock having a $.001 par value per share.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1419051/000149315225001670/0001493152-25-001670-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-01-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}